Candida Glabrata

Common Name(s)

Candida Glabrata

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Candida Glabrata" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Candida Glabrata" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Candida Glabrata" returned 214 free, full-text research articles on human participants. First 3 results:

Characterisation of an ABC transporter of a resistant Candida glabrata clinical isolate.
 

Author(s): Debora Afonso Silva Rocha, Leandro Figueira Reis de Sa, Ana Carolina Cartagenes Pinto, Maria de Lourdes Junqueira, Emiliana Mandarano da Silva, Ronaldo Mohana Borges, Antonio Ferreira-Pereira

Journal:

 

Candida glabrata ranks second in epidemiological surveillance studies, and is considered one of the main human yeast pathogens. Treatment of Candida infections represents a contemporary public health problem due to the limited availability of an antifungal arsenal, toxicity effects ...

Last Updated: 31 Dec 1969

Go To URL
Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That both Overlap and Are Distinct from Those Conferring Echinocandin Resistance.
 

Author(s): Cristina Jiménez-Ortigosa, Winder B Perez, David Angulo, Katyna Borroto-Esoda, David S Perlin

Journal:

 

SCY-078 is an orally active antifungal whose target is the β-(1,3)-d-glucan synthase (GS). We evaluated the spontaneous emergence of SCY-078-resistant isolates following drug exposure Resistant isolates were analyzed using broth microdilution methodology and sequencing. The kinetic ...

Last Updated: 31 Dec 1969

Go To URL
Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?
 

Author(s): Audrey Le, Dimitrios Farmakiotis, Jeffrey J Tarrand, Dimitrios P Kontoyiannis

Journal:

 

The 28-day crude mortality rate in 68 cancer patients with fluconazole-susceptible dose-dependent fungemia started on treatment (within 48 h after blood culture collection) with an echinocandin or liposomal amphotericin-B was better (30%) than those treated with azole monotherapy ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Candida Glabrata" returned 8 free, full-text review articles on human participants. First 3 results:

The birth of a deadly yeast: tracing the evolutionary emergence of virulence traits in Candida glabrata.
 

Author(s): Toni Gabaldón, Laia Carreté

Journal: FEMS Yeast Res.. 2016 Mar;16(2):fov110.

 

The yeast Candida glabrata is an opportunistic human fungal pathogen whose incidence has increased in the last two decades. Despite its name, this yeast is only distantly related to the model fungal pathogen C. albicans, and more closely related to Saccharomyces cerevisiae and other ...

Last Updated: 31 Dec 1969

Go To URL
Candida glabrata: new tools and technologies-expanding the toolkit.
 

Author(s): Hsueh-lui Ho, Ken Haynes

Journal: FEMS Yeast Res.. 2015 Sep;15(6):.

 

In recent years, there has been a noticeable rise in fungal infections related to non-albicans Candida species, including Candida glabrata which has both intrinsic resistance to and commonly acquired resistance to azole antifungals. Phylogenetically, C. glabrata is more closely related ...

Last Updated: 31 Dec 1969

Go To URL
Candida glabrata: a deadly companion?
 

Author(s): Monique Bolotin-Fukuhara, Cécile Fairhead

Journal: Yeast. 2014 Aug;31(8):279-88.

 

The yeast Candida glabrata has become a major fungal opportunistic pathogen of humans since the 1980s. Contrary to what its name suggests, it is much closer, phylogenetically, to the model yeast Saccharomyces cerevisiae than to the most prevalent human fungal pathogen, Candida albicans. ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.